Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: Diagnostic accuracy and clinical value

Journal of Gastroenterology

Volumn 38, Issue 2, 2003, Pages 121-126

  Hisabe, Takashi ^a   Matsui, Toshiyuki ^a   Sakurai, Toshihiro ^a   Murakami, Yuji ^a   Tanabe, Hiroshi ^a   Matake, Hiroaki ^a   Yao, Tsuneyoshi ^a   Kamachi, Shino ^b   Iwashita, Akinori ^b  

^a Fukuoka University Chikushi Hospital   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

ASCA; Crohn's disease; Ulcerative colitis

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE DURATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; HUMAN; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, FUNGAL; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; JAPAN; LIVER CIRRHOSIS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 0037300418     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300020     Document Type: Article

References (24)

1. Ruemmele FM, Targan SR, Levy G, Braun J, Seidman EG. Diagnostic accuracy of novel serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.
2. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-10.
3. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63.
4. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
5. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134:447-52.
6. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
7. Rutgeerts P, Vermeire S. Serological diagnosis of inflammatory bowel disease. Lancet 2000;356:2117-8.
8. Oshitani N, Hato F, Matsumoto T, Jinno Y, Sawa Y, Hara J, et al. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease. J Gastroenterol Hepatol 2000;15:1400-3.
9. Oshitani N, Hato F, Jinno Y, Sawa Y, Nakamura S, Matsumoto T, et al. IgG subclasses of anti-Saccharomyces cerevisiae antibody in inflammatory bowel disease. Eur J Clin Invest 2001;31:211-5.
10. Yao T. Criteria for diagnosis of Crohn's disease (preliminary proposal). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: The Ministry of Health and Welfare of Japan; 1996. p. 63-6.
11. Hiwatashi N. Criteria for diagnosis of ulcerative colitis (preliminary report). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: The Ministry of Health and Welfare of Japan; 1994. p. 90-2.
12. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1998;297:1105-6.
13. McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990;31:536-8.
14. Lindberg E, Magnusson KE, Tysk C, Jarnerot G. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozyotic twins with inflammatory bowel disease. Gut 1992;33:909-13.
15. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992;33:1071-5.
16. Dubinsky MC, Seidman EG. Diagnostic markers of inflammatory bowel disease. Curr Opin Gastroenterol 2000;16:337-42.
17. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, et al. Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.
18. Rump JA, Scholemerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990;181:406-13.
19. Shanahan F, Landers C, Duerr R, Targan SR. Neutrophil autoantibodies as disease markers for ulcerative colitis. Immunol Res 1991;10:479-84.
20. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic autoantibodies in ulcerative colitis: comparison with other colitis/diarrhoeal illnesses. Gastroenterology 1991;100:1590-9.
21. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47;487-96.
22. Price AB. Overlap in spectrum of non-specific inflammatory bowel disease-"colitis indeterminate". J Clin Pathol 1978;31: 567-77.
23. Wells AD, MacMillan I, Price AB, Ritchie JK, Nicholls RJ. Natural history of indeterminate colitis. Br J Surg 1991;78:179-81.
24. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325:928-37;1008-16.